Viewing Study NCT00616902


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-05-12 @ 8:49 PM
Study NCT ID: NCT00616902
Status: TERMINATED
Last Update Posted: 2012-01-20
First Post: 2008-02-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
Sponsor: Abbott
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M10-221
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View